Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

House Republicans suggest change to age rating in ACA

Rather than focusing on efforts to repeal or defund portions of the Affordable Care Act, House Republicans discussed five pieces of legislation aiming to make smaller changes to the law at a congressional hearing June 10

HHS analysis: ACA benefits rural communities

The Affordable Care Act has helped Americans living in rural areas get better access to more affordable care, HHS said. 

Brigham and Women’s nurses voting on strike while hospital plans lockout

More than 3,000 members of the Massachusetts Nurses Association will vote June 13 whether or not to continue working at Brigham and Women’s Hospital, the Boston Globe reports. That strike would last one day and could start any time after June 23, based on a 10-day strike notification agreement.

Thumbnail

State news: 5 states testing home health program, hallway beds draw complaints in N.Y.

Here’s a roundup of healthcare news from Florida, Illinois, Massachusetts, Michigan, New York, Maryland, Texas and New Hampshire.

Drugs prices are rising, but not as fast as you may think

An article by Forbes discusses healthcare costs, drug prices, government interventions and policy reform.

Largest health system in N.C. hit with antitrust lawsuit

Carolinas HealthCare System (CHS) is being accused of illegally keeping patients from lower-priced competitors by including steering restrictions in its contracts with insurers.

HHS funding bill advances to full Senate

For the second straight year, the appropriations bill covering HHS and its related agencies has been passed out of a Senate committee.

HHS emphasizes ACA success stories at forum

The heads of HHS and CMS tried to project confidence to insurers about the Affordable Care Act’s health insurance marketplaces after some of the largest companies announced plans to scale back their exchange offerings or proposed premium increases for 2017.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.